NMTC
Neuroone Medical Technologies CorpNASDAQ
Healthcare • Medical Devices
Updated 1 day ago
Coverage limited
$1.10+2.33%
Close Oct 13, 2026
- Market cap
- $9.61M
- 1 month
- -26.7%
- 3 months
- -56.2%
- 1 year
- -80.7%
- Dividend
- No dividends on record
- Short interest
- 2.9% of float178.7K shares · settled Sep 30, 2026 · +135.8% since Sep 15, 2026 · FINRA
Fundamentals · trailing 12 months to Jun 30, 2026
- Revenue
- $10M
- Net income
- -$7.15M
- Free cash flow
- -$7.16M
- Book value
- $3.77M
- Total debt
- $73.32K
- P/E
- —
- Price / sales
- 1×
- Price / book
- 2.6×
- FCF yield
- -74.5%
- Net margin
- -71.5%
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if NMTC is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Institutional coverage is still building for this ticker.
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: neutral
Last trade: buy 37 days ago
Red flags: 1
Largest 13-F holders · Q2 2026
27 filers reported a long position in NMTC for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
Q1 2026 shares are adjusted for the 2026-04-16 1-for-6 reverse split.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Bleichroeder LP | $2M | 666.7K | 0% |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.1M | 352.8K | +51.5% |
| BARD ASSOCIATES INC | $928.5K | 305.4K | -0.4% |
| PERKINS CAPITAL MANAGEMENT INC | $743.8K | 244.7K | -0.3% |
| GEODE CAPITAL MANAGEMENT, LLC | $284.4K | 93.6K | -8.8% |
| Sio Capital Management, LLC | $251.6K | 82.8K | 0% |
| RENAISSANCE TECHNOLOGIES LLC | $215.4K | 70.9K | -35.1% |
| VANGUARD FIDUCIARY TRUST CO | $149K | 49K | +0.7% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $132.5K | 43.6K | -0.2% |
| Cambridge Investment Research Advisors, Inc. | $87K | 28.5K | 0% |
Get the Full Analysis for NMTC
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.